QIAGEN and AstraZeneca Collaborate on CDx for Chronic Diseases
QIAGEN and AstraZeneca will develop a genotyping assay for companion diagnostics, advancing testing for therapies targeting chronic diseases.
Category: Company News
Company News
Latest
Company News
Latest
Agilent Acquires Sigsense, Creator of AI-enabled Lab Operations Technology
Agilent Technologies has acquired Sigsense Technologies, a startup specializing in AI and power monitoring to optimize lab operations.
Company News
Latest
Labcorp Announces New Strategic Service Offerings in Precision Oncology Portfolio
Labcorp's new strategic service offerings in its precision oncology portfolio enhance its role as a partner for biopharmaceutical companies.
Bio-Rad Announces Collaboration to Advance Personalized Monitoring of Solid Tumor Cancers
The goal is to support the implementation of Bio-Rad’s ddPCR technology for tumor-informed MRD monitoring of those with solid tumor cancer.
Read More
New England Biolabs Opens Subsidiary in the Republic of Korea
The Republic of Korea is emerging as a global leader in the life science space, due to strong public and private sector support, NEB says.
Read More
New England Biolabs Opens Applications for Passion in Science Awards
The Passion in Science Awards recognize members of the scientific community who are committed to making a difference.
Read More
Labcorp Acquires Select Assets of BioReference Health’s Diagnostics Business
Labcorp is set to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health, Inc.
Read More
The Prelude Network Names Labcorp Its Preferred Genetic Carrier Screening Lab
Labcorp has long been a partner to Prelude and its network, providing clinical laboratory and FDA-approved donor testing within each clinic.
Read More
Babson Diagnostics to Launch Blood Test Service with Retail Partners
The BetterWay blood test is designed to be less invasive and more convenient and accessible for consumers.
Read More
Bio-Rad Gets Sustainability Certification
Bio-Rad Labs received the “My Green Lab” certification for its R&D facilities, marking a new sustainability milestone for the company.
Read More
Ambry Genetics and Tempus Collaborate on Germline and Somatic Testing Services
Ambry is performing germline sequencing assays for Tempus, powered by Ambry’s CancerNext and CancerNext-Expanded assays.
Read More
Key Proteo’s Clinical Lab Expansion Plans Include New CLIA-Certified Lab
Key Proteo has initiated plans to build a new CLIA-certified laboratory as part of its growth strategy to enhance newborn screening programs.
Read More
Bruker Announces Agreement to Acquire ELITechGroup
Bruker Corporation has entered into a definitive share purchase agreement with TecFin S.à r.l. to acquire ELITechGroup.
Read More
Mountain View Medical Laboratory Rebrands as Gnosis
California-based Mountain View Medical Laboratory has announced a complete rebranding of its business to become “Gnosis.”
Read More
QuidelOrtho’s Executive Leadership Gets Shake Up
To ensure business continuity and effective leadership, the Board formed the Office of the Chief Executive Officer, led by Michael Iskra.
Read More
Abbott and Fujirebio Partner to Develop Neurofilament-light Chain Neurology Biomarker Assay
Abbott is exploring research use pathway for new biomarkers to support faster development of diagnostics and therapeutics.
Read More
Beckman Coulter Diagnostics Names New President
Beckman Coulter Diagnostics announced its new president who has previous experience running a complex operating division as president.
Read More
ArteraAI Secures Funding to Personalize Cancer Therapy With Multimodal AI
The funding aims to propel ArteraAI forward in its mission to personalize cancer therapy through AI-enabled predictive and prognostic tests.
Read More